Calibrate, which began prescribing anti-obesity medications in 2020 as part of a weight loss program, prominently describes the drugs as a "temporary aid to improve your metabolic health." In Denmark, a venture-backed startup, Embla, says on its website that it offers GLP-1s "always with the clear aim of a healthy transition off medication once you've reached your goals." (Other companies, including the weight-loss giant WeightWatchers and more recent incumbents such as Ro, have begun dabbling in GLP-1 medications, too, though they are clear in their messaging that these drugs are meant to be taken long-term.) A spokeswoman for Noom frames the issue as partly one of customer demand: When asked about the company's marketing of Ozempic as a drug to take for a limited time, she emphasized that most patients don't want to stay on the medications forever, noting that research showing that "68% of people stop taking the GLP-1 by month 12 suggests a reticence to a forever medication by many

Medications: You can take most prescription and non-prescription medications right up to the day of the colonoscopy
Emerging pathophysiological roles of ketone bodies
Lenzi A, Gandini L, Picardo M, Tramer F, Sandri G, Panfili E
To summarize some of what has been been shown in the studies cited in this article: Its important to note that some of these studies used NAC along with other treatments
Using supplements responsibly under professional supervision minimizes potential risks and helps ensure they are part of safe, effective autism management